Sumer Jacquelyn L
CIK 0001844824
Chief Legal Officer
Filings
17
Latest Feb 25, 2026
Issuers covered
2
Showing
17 of 17
Page 1
Track record
11 of 12 open-market trades scored (92% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 64% | -4.5% | +4.0% | +16.4% | -48.5% |
| 90 days | 11 | 27% | -15.4% | -10.3% | +23.1% | -67.8% |
| 180 days | 8 | 63% | -14.1% | +9.2% | +30.1% | -108.3% |
| 365 days | 8 | 13% | -52.8% | -38.2% | +7.3% | -163.3% |
Issuers
Companies where Sumer Jacquelyn L has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CGEM | Cullinan Oncology, Inc. | 15 | Feb 25, 2026 |
| GNCA | Genocea Biosciences, Inc. | 2 | Jun 2, 2022 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|